BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ogino S, Lochhead P, Chan AT, Nishihara R, Cho E, Wolpin BM, Meyerhardt JA, Meissner A, Schernhammer ES, Fuchs CS, Giovannucci E. Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease. Mod Pathol 2013;26:465-84. [PMID: 23307060 DOI: 10.1038/modpathol.2012.214] [Cited by in Crossref: 151] [Cited by in F6Publishing: 138] [Article Influence: 18.9] [Reference Citation Analysis]
Number Citing Articles
1 Li SKH, Martin A. Mismatch Repair and Colon Cancer: Mechanisms and Therapies Explored. Trends Mol Med. 2016;22:274-289. [PMID: 26970951 DOI: 10.1016/j.molmed.2016.02.003] [Cited by in Crossref: 73] [Cited by in F6Publishing: 63] [Article Influence: 14.6] [Reference Citation Analysis]
2 Aghamir SMK, Heshmat R, Ebrahimi M, Ketabchi SE, Parichehreh Dizaji S, Khatami F. The Impact Of Succinate Dehydrogenase Gene (SDH) Mutations In Renal Cell Carcinoma (RCC): A Systematic Review. Onco Targets Ther 2019;12:7929-40. [PMID: 31579262 DOI: 10.2147/OTT.S207460] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
3 Heitzer E, Artl M, Filipits M, Resel M, Graf R, Weißenbacher B, Lax S, Gnant M, Wrba F, Greil R, Dietze O, Hofbauer F, Böhm G, Höfler G, Samonigg H, Schaberl-Moser R, Balic M, Dandachi N. Differential survival trends of stage II colorectal cancer patients relate to promoter methylation status of PCDH10, SPARC, and UCHL1. Mod Pathol 2014;27:906-15. [PMID: 24309322 DOI: 10.1038/modpathol.2013.204] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
4 Susanti NMP, Tjahjono DH. Cyclin-Dependent Kinase 4 and 6 Inhibitors in Cell Cycle Dysregulation for Breast Cancer Treatment. Molecules 2021;26:4462. [PMID: 34361615 DOI: 10.3390/molecules26154462] [Reference Citation Analysis]
5 Esterhuyse MM, Kaufmann SH. Diagnostic biomarkers are hidden in the infected host's epigenome. Expert Rev Mol Diagn 2013;13:625-37. [PMID: 23895131 DOI: 10.1586/14737159.2013.811897] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
6 Begg CB, Seshan VE, Zabor EC, Furberg H, Arora A, Shen R, Maranchie JK, Nielsen ME, Rathmell WK, Signoretti S, Tamboli P, Karam JA, Choueiri TK, Hakimi AA, Hsieh JJ. Genomic investigation of etiologic heterogeneity: methodologic challenges. BMC Med Res Methodol 2014;14:138. [PMID: 25532962 DOI: 10.1186/1471-2288-14-138] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
7 Deng J, Zhou D, Zhang J, Chen Y, Wang C, Liu Y, Zhao K. Aberrant methylation of the TERT promoter in esophageal squamous cell carcinoma. Cancer Genet 2015;208:602-9. [PMID: 26669682 DOI: 10.1016/j.cancergen.2015.10.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
8 Zhang W, Peng C, Zheng M, Gao W, Zhu J, Lv T, Liu L, Liu Z, Li H, Xv Y, Tian J. Prenatal alcohol exposure causes the over-expression of DHAND and EHAND by increasing histone H3K14 acetylation in C57 BL/6 mice. Toxicol Lett 2014;228:140-6. [PMID: 24857828 DOI: 10.1016/j.toxlet.2014.05.011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
9 Li Z, Guo X, Tang L, Peng L, Chen M, Luo X, Wang S, Xiao Z, Deng Z, Dai L, Xia K, Wang J. Methylation analysis of plasma cell-free DNA for breast cancer early detection using bisulfite next-generation sequencing. Tumour Biol 2016;37:13111-9. [PMID: 27449045 DOI: 10.1007/s13277-016-5190-z] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
10 Xia YY, Ding YB, Liu XQ, Chen XM, Cheng SQ, Li LB, Ma MF, He JL, Wang YX. Racial/ethnic disparities in human DNA methylation. Biochim Biophys Acta 2014;1846:258-62. [PMID: 25016140 DOI: 10.1016/j.bbcan.2014.07.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
11 Wang M, Kuchiba A, Ogino S. A Meta-Regression Method for Studying Etiological Heterogeneity Across Disease Subtypes Classified by Multiple Biomarkers. Am J Epidemiol 2015;182:263-70. [PMID: 26116215 DOI: 10.1093/aje/kwv040] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 5.2] [Reference Citation Analysis]
12 Verma M, Kumar V. Epigenetic Biomarkers in Colorectal Cancer. Mol Diagn Ther 2017;21:153-65. [DOI: 10.1007/s40291-016-0244-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
13 Kuller LH. The limitations of opportunistic epidemiology, pseudopod epidemiology. Eur J Epidemiol 2016;31:957-66. [DOI: 10.1007/s10654-016-0196-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
14 Lochhead P, Chan AT, Nishihara R, Fuchs CS, Beck AH, Giovannucci E, Ogino S. Etiologic field effect: reappraisal of the field effect concept in cancer predisposition and progression. Mod Pathol 2015;28:14-29. [PMID: 24925058 DOI: 10.1038/modpathol.2014.81] [Cited by in Crossref: 100] [Cited by in F6Publishing: 100] [Article Influence: 14.3] [Reference Citation Analysis]
15 Akimoto N, Zhao M, Ugai T, Zhong R, Lau MC, Fujiyoshi K, Kishikawa J, Haruki K, Arima K, Twombly TS, Zhang X, Giovannucci EL, Wu K, Song M, Chan AT, Cao Y, Meyerhardt JA, Ng K, Giannakis M, Väyrynen JP, Nowak JA, Ogino S. Tumor Long Interspersed Nucleotide Element-1 (LINE-1) Hypomethylation in Relation to Age of Colorectal Cancer Diagnosis and Prognosis. Cancers (Basel) 2021;13:2016. [PMID: 33922024 DOI: 10.3390/cancers13092016] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Nishi A, Kawachi I, Koenen KC, Wu K, Nishihara R, Ogino S. Lifecourse epidemiology and molecular pathological epidemiology. Am J Prev Med. 2015;48:116-119. [PMID: 25528613 DOI: 10.1016/j.amepre.2014.09.031] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
17 Mas VR, Le TH, Maluf DG. Epigenetics in Kidney Transplantation: Current Evidence, Predictions, and Future Research Directions. Transplantation 2016;100:23-38. [PMID: 26356174 DOI: 10.1097/TP.0000000000000878] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
18 Ferioli M, Zauli G, Maiorano P, Milani D, Mirandola P, Neri LM. Role of physical exercise in the regulation of epigenetic mechanisms in inflammation, cancer, neurodegenerative diseases, and aging process. J Cell Physiol 2019. [PMID: 30767204 DOI: 10.1002/jcp.28304] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 11.5] [Reference Citation Analysis]
19 Majnik AV, Lane RH. The relationship between early-life environment, the epigenome and the microbiota. Epigenomics 2015;7:1173-84. [DOI: 10.2217/epi.15.74] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
20 Sahnane N, Magnoli F, Bernasconi B, Tibiletti MG, Romualdi C, Pedroni M, Ponz de Leon M, Magnani G, Reggiani-Bonetti L, Bertario L, Signoroni S, Capella C, Sessa F, Furlan D; AIFEG. Aberrant DNA methylation profiles of inherited and sporadic colorectal cancer. Clin Epigenetics 2015;7:131. [PMID: 26697123 DOI: 10.1186/s13148-015-0165-2] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 5.7] [Reference Citation Analysis]
21 Hanyuda A, Kim SA, Martinez-Fernandez A, Qian ZR, Yamauchi M, Nishihara R, Morikawa T, Liao X, Inamura K, Mima K, Cao Y, Zhang X, Wu K, Chan AT, Giovannucci EL, Meyerhardt JA, Fuchs CS, Shivdasani RA, Ogino S. Survival Benefit of Exercise Differs by Tumor IRS1 Expression Status in Colorectal Cancer. Ann Surg Oncol. 2016;23:908-917. [PMID: 26577117 DOI: 10.1245/s10434-015-4967-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
22 Zakhari S, Hoek JB. Epidemiology of Moderate Alcohol Consumption and Breast Cancer: Association or Causation? Cancers (Basel) 2018;10:E349. [PMID: 30249004 DOI: 10.3390/cancers10100349] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
23 Campbell PT, Rebbeck TR, Nishihara R, Beck AH, Begg CB, Bogdanov AA, Cao Y, Coleman HG, Freeman GJ, Heng YJ, Huttenhower C, Irizarry RA, Kip NS, Michor F, Nevo D, Peters U, Phipps AI, Poole EM, Qian ZR, Quackenbush J, Robins H, Rogan PK, Slattery ML, Smith-Warner SA, Song M, VanderWeele TJ, Xia D, Zabor EC, Zhang X, Wang M, Ogino S. Proceedings of the third international molecular pathological epidemiology (MPE) meeting. Cancer Causes Control 2017;28:167-76. [PMID: 28097472 DOI: 10.1007/s10552-016-0845-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
24 Li D, Li P, Wu J, Yi J, Dou Y, Guo X, Yin Y, Wang D, Ma C, Qiu L. Methylation of NBPF1 as a novel marker for the detection of plasma cell-free DNA of breast cancer patients. Clinica Chimica Acta 2018;484:81-6. [DOI: 10.1016/j.cca.2018.05.030] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
25 Myte R, Gylling B, Häggström J, Häggström C, Zingmark C, Löfgren Burström A, Palmqvist R, Van Guelpen B. Metabolic factors and the risk of colorectal cancer by KRAS and BRAF mutation status. Int J Cancer 2019;145:327-37. [PMID: 30613980 DOI: 10.1002/ijc.32104] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
26 Blanco-Calvo M, Concha Á, Figueroa A, Garrido F, Valladares-Ayerbes M. Colorectal Cancer Classification and Cell Heterogeneity: A Systems Oncology Approach. Int J Mol Sci 2015;16:13610-32. [PMID: 26084042 DOI: 10.3390/ijms160613610] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 6.3] [Reference Citation Analysis]
27 van Nierop M, Bak M, de Graaf R, Ten Have M, van Dorsselaer S, van Winkel R; Genetic Risk and Outcome of Psychosis (GROUP) Investigators. The functional and clinical relevance of childhood trauma-related admixture of affective, anxious and psychosis symptoms. Acta Psychiatr Scand 2016;133:91-101. [PMID: 25961128 DOI: 10.1111/acps.12437] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
28 Guler I, Askan G, Klostergaard J, Sahin IH. Precision medicine for metastatic colorectal cancer: an evolving era. Expert Rev Gastroenterol Hepatol. 2019;13:919-931. [PMID: 31475851 DOI: 10.1080/17474124.2019.1663174] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
29 Nishi A. Evolution and social epidemiology. Social Science & Medicine 2015;145:132-7. [DOI: 10.1016/j.socscimed.2015.08.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
30 Leu HB, Yin WH, Tseng WK, Wu YW, Lin TH, Yeh HI, Chang KC, Wang JH, Wu CC, Chen JW. Identification of new biosignatures for clinical outcomes in stable coronary artery disease - The study protocol and initial observations of a prospective follow-up study in Taiwan. BMC Cardiovasc Disord 2017;17:42. [PMID: 28129736 DOI: 10.1186/s12872-017-0471-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
31 Ogino S, Jhun I, Mata DA, Soong TR, Hamada T, Liu L, Nishihara R, Giannakis M, Cao Y, Manson JE, Nowak JA, Chan AT. Integration of pharmacology, molecular pathology, and population data science to support precision gastrointestinal oncology. NPJ Precis Oncol 2017;1:40. [PMID: 29552640 DOI: 10.1038/s41698-017-0042-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
32 Tigchelaar EF, Zhernakova A, Dekens JA, Hermes G, Baranska A, Mujagic Z, Swertz MA, Muñoz AM, Deelen P, Cénit MC, Franke L, Scholtens S, Stolk RP, Wijmenga C, Feskens EJ. Cohort profile: LifeLines DEEP, a prospective, general population cohort study in the northern Netherlands: study design and baseline characteristics. BMJ Open 2015;5:e006772. [PMID: 26319774 DOI: 10.1136/bmjopen-2014-006772] [Cited by in Crossref: 130] [Cited by in F6Publishing: 97] [Article Influence: 21.7] [Reference Citation Analysis]
33 Dou R, Ng K, Giovannucci EL, Manson JE, Qian ZR, Ogino S. Vitamin D and colorectal cancer: molecular, epidemiological and clinical evidence. Br J Nutr 2016;115:1643-60. [PMID: 27245104 DOI: 10.1017/S0007114516000696] [Cited by in Crossref: 66] [Cited by in F6Publishing: 38] [Article Influence: 16.5] [Reference Citation Analysis]
34 Szylberg Ł, Janiczek M, Popiel A, Marszałek A. Serrated polyps and their alternative pathway to the colorectal cancer: a systematic review. Gastroenterol Res Pract 2015;2015:573814. [PMID: 25945086 DOI: 10.1155/2015/573814] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 4.7] [Reference Citation Analysis]
35 Chen DH, Yu JW, Jiang BJ. Contactin 1: A potential therapeutic target and biomarker in gastric cancer. World J Gastroenterol 2015;21:9707-16. [PMID: 26361417 DOI: 10.3748/wjg.v21.i33.9707] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
36 Advani SM, Swartz MD, Loree J, Davis JS, Sarsashek AM, Lam M, Lee MS, Bressler J, Lopez DS, Daniel CR, Morris V, Shureqi I, Kee B, Dasari A, Vilar E, Overman M, Hamilton S, Maru D, Braithwaite D, Kopetz S. Epidemiology and Molecular-Pathologic Characteristics of CpG Island Methylator Phenotype (CIMP) in Colorectal Cancer. Clin Colorectal Cancer 2021;20:137-147.e1. [PMID: 33229221 DOI: 10.1016/j.clcc.2020.09.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
37 Mima K, Nishihara R, Qian ZR, Cao Y, Sukawa Y, Nowak JA, Yang J, Dou R, Masugi Y, Song M, Kostic AD, Giannakis M, Bullman S, Milner DA, Baba H, Giovannucci EL, Garraway LA, Freeman GJ, Dranoff G, Garrett WS, Huttenhower C, Meyerson M, Meyerhardt JA, Chan AT, Fuchs CS, Ogino S. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. Gut. 2016;65:1973-1980. [PMID: 26311717 DOI: 10.1136/gutjnl-2015-310101] [Cited by in Crossref: 344] [Cited by in F6Publishing: 307] [Article Influence: 57.3] [Reference Citation Analysis]
38 Jatho A, Tran BT, Cambia JM, Nanyingi M, Mugisha NM. Cancer Risk Studies and Priority Areas for Cancer Risk Appraisal in Uganda. Ann Glob Health 2020;86:78. [PMID: 32704483 DOI: 10.5334/aogh.2873] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
39 Wang M, Spiegelman D, Kuchiba A, Lochhead P, Kim S, Chan AT, Poole EM, Tamimi R, Tworoger SS, Giovannucci E, Rosner B, Ogino S. Statistical methods for studying disease subtype heterogeneity. Stat Med 2016;35:782-800. [PMID: 26619806 DOI: 10.1002/sim.6793] [Cited by in Crossref: 136] [Cited by in F6Publishing: 129] [Article Influence: 22.7] [Reference Citation Analysis]
40 Burggren WW. Dynamics of epigenetic phenomena: intergenerational and intragenerational phenotype 'washout'. J Exp Biol 2015;218:80-7. [PMID: 25568454 DOI: 10.1242/jeb.107318] [Cited by in Crossref: 71] [Cited by in F6Publishing: 52] [Article Influence: 11.8] [Reference Citation Analysis]
41 Cao X, Li K, Xu X, Deneen KMV, Geng G, Chen X. Development of tomographic reconstruction for three-dimensional optical imaging: From the inversion of light propagation to artificial intelligence. AIMI 2020;1:78-86. [DOI: 10.35711/aimi.v1.i2.78] [Reference Citation Analysis]
42 Ohadian Moghadam S, Momeni SA. Human microbiome and prostate cancer development: current insights into the prevention and treatment. Front Med 2021;15:11-32. [PMID: 32607819 DOI: 10.1007/s11684-019-0731-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Yu Y, Wang H, Rao X, Liu L, Zheng P, Li W, Zhou W, Chai T, Ji P, Song J, Wei H, Xie P. Proteomic Profiling of Lysine Acetylation Indicates Mitochondrial Dysfunction in the Hippocampus of Gut Microbiota-Absent Mice. Front Mol Neurosci 2021;14:594332. [PMID: 33776647 DOI: 10.3389/fnmol.2021.594332] [Reference Citation Analysis]
44 Liu L, Nevo D, Nishihara R, Cao Y, Song M, Twombly TS, Chan AT, Giovannucci EL, VanderWeele TJ, Wang M, Ogino S. Utility of inverse probability weighting in molecular pathological epidemiology. Eur J Epidemiol 2018;33:381-92. [PMID: 29264788 DOI: 10.1007/s10654-017-0346-8] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 7.8] [Reference Citation Analysis]
45 Roos L, van Dongen J, Bell CG, Burri A, Deloukas P, Boomsma DI, Spector TD, Bell JT. Integrative DNA methylome analysis of pan-cancer biomarkers in cancer discordant monozygotic twin-pairs. Clin Epigenetics 2016;8:7. [PMID: 26798410 DOI: 10.1186/s13148-016-0172-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 4.4] [Reference Citation Analysis]
46 Sirniö P, Tuomisto A, Tervahartiala T, Sorsa T, Klintrup K, Karhu T, Herzig KH, Mäkelä J, Karttunen TJ, Salo T, Mäkinen MJ, Väyrynen JP. High-serum MMP-8 levels are associated with decreased survival and systemic inflammation in colorectal cancer. Br J Cancer 2018;119:213-9. [PMID: 29808017 DOI: 10.1038/s41416-018-0136-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
47 Hanyuda A, Cao Y, Hamada T, Nowak JA, Qian ZR, Masugi Y, da Silva A, Liu L, Kosumi K, Soong TR, Jhun I, Wu K, Zhang X, Song M, Meyerhardt JA, Chan AT, Fuchs CS, Giovannucci EL, Ogino S, Nishihara R. Body mass index and risk of colorectal carcinoma subtypes classified by tumor differentiation status. Eur J Epidemiol 2017;32:393-407. [PMID: 28510098 DOI: 10.1007/s10654-017-0254-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
48 Ohno T, Adachi S, Okuno M, Horibe Y, Goto N, Iwama M, Yamauchi O, Kojima T, Saito K, Ibuka T, Yasuda I, Araki H, Moriwaki H, Shimizu M. Development of a Novel Scoring System for Predicting the Risk of Colorectal Neoplasia: A Retrospective Study. PLoS One 2016;11:e0157269. [PMID: 27284907 DOI: 10.1371/journal.pone.0157269] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
49 van Winkel R. Aetiological stratification as a conceptual framework for gene-by-environment interaction research in psychiatry. Epidemiol Psychiatr Sci 2015;24:6-11. [PMID: 25693861 DOI: 10.1017/S2045796014000559] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
50 Pirini F, Guida E, Lawson F, Mancinelli A, Guerrero-Preston R. Nuclear and mitochondrial DNA alterations in newborns with prenatal exposure to cigarette smoke. Int J Environ Res Public Health 2015;12:1135-55. [PMID: 25648174 DOI: 10.3390/ijerph120201135] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
51 Nemec S, Kilian KA. Materials control of the epigenetics underlying cell plasticity. Nat Rev Mater 2021;6:69-83. [DOI: 10.1038/s41578-020-00238-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 8.0] [Reference Citation Analysis]
52 Li B, Gan A, Chen X, Wang X, He W, Zhang X, Huang R, Zhou S, Song X, Xu A. Diagnostic Performance of DNA Hypermethylation Markers in Peripheral Blood for the Detection of Colorectal Cancer: A Meta-Analysis and Systematic Review. PLoS One. 2016;11:e0155095. [PMID: 27158984 DOI: 10.1371/journal.pone.0155095] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
53 Myte R, Gylling B, Häggström J, Schneede J, Löfgren-Burström A, Huyghe JR, Hallmans G, Meyer K, Johansson I, Ueland PM, Palmqvist R, Van Guelpen B. One-carbon metabolism biomarkers and genetic variants in relation to colorectal cancer risk by KRAS and BRAF mutation status. PLoS One 2018;13:e0196233. [PMID: 29694444 DOI: 10.1371/journal.pone.0196233] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
54 Li YY, Ge QX, Cao J, Zhou YJ, Du YL, Shen B, Wan YJ, Nie YQ. Association of Fusobacterium nucleatum infection with colorectal cancer in Chinese patients. World J Gastroenterol 2016;22:3227-33. [PMID: 27004000 DOI: 10.3748/wjg.v22.i11.3227] [Cited by in CrossRef: 79] [Cited by in F6Publishing: 71] [Article Influence: 19.8] [Reference Citation Analysis]
55 Yamauchi M, Lochhead P, Imamura Y, Kuchiba A, Liao X, Qian ZR, Nishihara R, Morikawa T, Shima K, Wu K, Giovannucci E, Meyerhardt JA, Fuchs CS, Chan AT, Ogino S. Physical activity, tumor PTGS2 expression, and survival in patients with colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2013;22:1142-1152. [PMID: 23629521 DOI: 10.1158/1055-9965.epi-13-0108] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
56 Yu N, Zhu H, Tao Y, Huang Y, Song X, Zhou Y, Li Y, Pei Q, Tan Q, Pei H. Association between prognostic survival of human colorectal carcinoma and ZNRF3 expression. Onco Targets Ther 2016;9:6679-87. [PMID: 27822070 DOI: 10.2147/OTT.S108134] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
57 Hart NH, Galvão DA, Saunders C, Taaffe DR, Feeney KT, Spry NA, Tsoi D, Martin H, Chee R, Clay T, Redfern AD, Newton RU. Mechanical suppression of osteolytic bone metastases in advanced breast cancer patients: a randomised controlled study protocol evaluating safety, feasibility and preliminary efficacy of exercise as a targeted medicine. Trials 2018;19:695. [PMID: 30572928 DOI: 10.1186/s13063-018-3091-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
58 Blomain ES, Pattison AM, Waldman SA. GUCY2C ligand replacement to prevent colorectal cancer. Cancer Biol Ther 2016;17:713-8. [PMID: 27104761 DOI: 10.1080/15384047.2016.1178429] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
59 Gilsing AMJ, Weijenberg MP, Goldbohm RA, Dagnelie PC, van den Brandt PA, Schouten LJ. Vegetarianism, low meat consumption and the risk of lung, postmenopausal breast and prostate cancer in a population-based cohort study. Eur J Clin Nutr 2016;70:723-9. [DOI: 10.1038/ejcn.2016.25] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
60 Ma S, Ogino S, Parsana P, Nishihara R, Qian Z, Shen J, Mima K, Masugi Y, Cao Y, Nowak JA, Shima K, Hoshida Y, Giovannucci EL, Gala MK, Chan AT, Fuchs CS, Parmigiani G, Huttenhower C, Waldron L. Continuity of transcriptomes among colorectal cancer subtypes based on meta-analysis. Genome Biol 2018;19:142. [PMID: 30253799 DOI: 10.1186/s13059-018-1511-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
61 Sun Y, Zhang Z, Zheng CQ, Sang LX. Mucosal lesions of the upper gastrointestinal tract in patients with ulcerative colitis: A review. World J Gastroenterol 2021;27:2963-78. [PMID: 34168401 DOI: 10.3748/wjg.v27.i22.2963] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Kuller LH. Epidemiology: Then and Now. Am J Epidemiol 2016;183:372-80. [PMID: 26493266 DOI: 10.1093/aje/kwv158] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
63 Lochhead P, Chan AT, Giovannucci E, Fuchs CS, Wu K, Nishihara R, O'Brien M, Ogino S. Progress and opportunities in molecular pathological epidemiology of colorectal premalignant lesions. Am J Gastroenterol 2014;109:1205-14. [PMID: 24935274 DOI: 10.1038/ajg.2014.153] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 5.4] [Reference Citation Analysis]
64 Ashktorab H, Washington K, Zarnogi S, Shakoori A, Varma S, Lee E, Shokrani B, Laiyemo A, Brim H. Determination of distinctive hypomethylated genes in African American colorectal neoplastic lesions. Therap Adv Gastroenterol 2020;13:1756284820905482. [PMID: 32547637 DOI: 10.1177/1756284820905482] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
65 Lochhead P, Kuchiba A, Imamura Y, Liao X, Yamauchi M, Nishihara R, Qian ZR, Morikawa T, Shen J, Meyerhardt JA, Fuchs CS, Ogino S. Microsatellite instability and BRAF mutation testing in colorectal cancer prognostication. J Natl Cancer Inst. 2013;105:1151-1156. [PMID: 23878352 DOI: 10.1093/jnci/djt173] [Cited by in Crossref: 262] [Cited by in F6Publishing: 241] [Article Influence: 32.8] [Reference Citation Analysis]
66 Jung S, Qian ZR, Yamauchi M, Bertrand KA, Fitzgerald KC, Inamura K, Kim SA, Mima K, Sukawa Y, Zhang X, Wang M, Smith-Warner SA, Wu K, Fuchs CS, Chan AT, Giovannucci EL, Ng K, Cho E, Ogino S, Nishihara R. Predicted 25(OH)D score and colorectal cancer risk according to vitamin D receptor expression. Cancer Epidemiol Biomarkers Prev 2014;23:1628-37. [PMID: 24920642 DOI: 10.1158/1055-9965.EPI-14-0229] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
67 Vogtmann E, Corley DA, Almers LM, Cardwell CR, Murray LJ, Abnet CC. Oral Bisphosphonate Exposure and the Risk of Upper Gastrointestinal Cancers. PLoS One 2015;10:e0140180. [PMID: 26445463 DOI: 10.1371/journal.pone.0140180] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
68 Martinez-Useros J, Garcia-Foncillas J. Obesity and colorectal cancer: molecular features of adipose tissue. J Transl Med 2016;14:21. [PMID: 26801617 DOI: 10.1186/s12967-016-0772-5] [Cited by in Crossref: 70] [Cited by in F6Publishing: 66] [Article Influence: 14.0] [Reference Citation Analysis]
69 Li W, Qiu T, Ling Y, Guo L, Li L, Ying J. Molecular pathological epidemiology of colorectal cancer in Chinese patients with KRAS and BRAF mutations. Oncotarget. 2015;6:39607-39613. [PMID: 26530529 DOI: 10.18632/oncotarget.5551] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
70 Blomain ES, Waldman SA. Does obesity promote the development of colorectal cancer? Expert Rev Anticancer Ther 2016;16:465-7. [PMID: 26943700 DOI: 10.1586/14737140.2016.1162102] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
71 Nishihara R, Wang M, Qian ZR, Baba Y, Yamauchi M, Mima K, Sukawa Y, Kim SA, Inamura K, Zhang X, Wu K, Giovannucci EL, Chan AT, Fuchs CS, Ogino S, Schernhammer ES. Alcohol, one-carbon nutrient intake, and risk of colorectal cancer according to tumor methylation level of IGF2 differentially methylated region. Am J Clin Nutr. 2014;100:1479-1488. [PMID: 25411283 DOI: 10.3945/ajcn.114.095539] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
72 Shankar K, Pivik RT, Johnson SL, van Ommen B, Demmer E, Murray R. Environmental Forces that Shape Early Development: What We Know and Still Need to Know. Curr Dev Nutr 2018;2:nzx002. [PMID: 30167570 DOI: 10.3945/cdn.117.001826] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
73 Goliwas KF, Miller LM, Marshall LE, Berry JL, Frost AR. Preparation and Analysis of In Vitro Three Dimensional Breast Carcinoma Surrogates. J Vis Exp 2016. [PMID: 27214165 DOI: 10.3791/54004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
74 McCartney DL, Stevenson AJ, Hillary RF, Walker RM, Bermingham ML, Morris SW, Clarke TK, Campbell A, Murray AD, Whalley HC, Porteous DJ, Visscher PM, McIntosh AM, Evans KL, Deary IJ, Marioni RE. Epigenetic signatures of starting and stopping smoking. EBioMedicine 2018;37:214-20. [PMID: 30389506 DOI: 10.1016/j.ebiom.2018.10.051] [Cited by in Crossref: 29] [Cited by in F6Publishing: 15] [Article Influence: 9.7] [Reference Citation Analysis]
75 Dai J, Nishi A, Tran N, Yamamoto Y, Dewey G, Ugai T, Ogino S. Revisiting social MPE: an integration of molecular pathological epidemiology and social science in the new era of precision medicine. Expert Rev Mol Diagn 2021;:1-18. [PMID: 34253130 DOI: 10.1080/14737159.2021.1952073] [Reference Citation Analysis]
76 Zhou L, Wang K, Li Q, Nice EC, Zhang H, Huang C. Clinical proteomics-driven precision medicine for targeted cancer therapy: current overview and future perspectives. Expert Rev Proteomics 2016;13:367-81. [PMID: 26923776 DOI: 10.1586/14789450.2016.1159959] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
77 Wild CP, Bucher JR, de Jong BW, Dillner J, von Gertten C, Groopman JD, Herceg Z, Holmes E, Holmila R, Olsen JH, Ringborg U, Scalbert A, Shibata T, Smith MT, Ulrich C, Vineis P, McLaughlin J. Translational cancer research: balancing prevention and treatment to combat cancer globally. J Natl Cancer Inst 2015;107:353. [PMID: 25515230 DOI: 10.1093/jnci/dju353] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
78 Chu SK, Yang HC. Interethnic DNA methylation difference and its implications in pharmacoepigenetics. Epigenomics 2017;9:1437-54. [PMID: 28882057 DOI: 10.2217/epi-2017-0046] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
79 Shaheen NJ. What is behind the remarkable increase in esophageal adenocarcinoma? Am J Gastroenterol 2014;109:345-7. [PMID: 24594951 DOI: 10.1038/ajg.2014.35] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
80 Cebola I, Custodio J, Muñoz M, Díez-Villanueva A, Paré L, Prieto P, Aussó S, Coll-Mulet L, Boscá L, Moreno V, Peinado MA. Epigenetics override pro-inflammatory PTGS transcriptomic signature towards selective hyperactivation of PGE2 in colorectal cancer. Clin Epigenetics 2015;7:74. [PMID: 26207152 DOI: 10.1186/s13148-015-0110-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
81 Marwitz S, Scheufele S, Perner S, Reck M, Ammerpohl O, Goldmann T. Epigenetic modifications of the immune-checkpoint genes CTLA4 and PDCD1 in non-small cell lung cancer results in increased expression. Clin Epigenetics 2017;9:51. [PMID: 28503213 DOI: 10.1186/s13148-017-0354-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 7.5] [Reference Citation Analysis]
82 Zakhari S, Hoek JB. Alcohol and breast cancer: reconciling epidemiological and molecular data. Adv Exp Med Biol 2015;815:7-39. [PMID: 25427899 DOI: 10.1007/978-3-319-09614-8_2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
83 Coppedè F. The role of epigenetics in colorectal cancer. Expert Rev Gastroenterol Hepatol 2014;8:935-48. [PMID: 24871610 DOI: 10.1586/17474124.2014.924397] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
84 Wang Y, Chen PM, Liu RB. Advance in plasma SEPT9 gene methylation assay for colorectal cancer early detection. World J Gastrointest Oncol. 2018;10:15-22. [PMID: 29375744 DOI: 10.4251/wjgo.v10.i1.15] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 17] [Article Influence: 7.3] [Reference Citation Analysis]
85 Bae JM, Kim JH, Cho NY, Kim TY, Kang GH. Prognostic implication of the CpG island methylator phenotype in colorectal cancers depends on tumour location. Br J Cancer. 2013;109:1004-1012. [PMID: 23900220 DOI: 10.1038/bjc.2013.430] [Cited by in Crossref: 81] [Cited by in F6Publishing: 76] [Article Influence: 10.1] [Reference Citation Analysis]
86 Mikeska T, Craig JM. DNA methylation biomarkers: cancer and beyond. Genes (Basel). 2014;5:821-864. [PMID: 25229548 DOI: 10.3390/genes5030821] [Cited by in Crossref: 162] [Cited by in F6Publishing: 131] [Article Influence: 23.1] [Reference Citation Analysis]
87 Parfett CL, Desaulniers D. A Tox21 Approach to Altered Epigenetic Landscapes: Assessing Epigenetic Toxicity Pathways Leading to Altered Gene Expression and Oncogenic Transformation In Vitro. Int J Mol Sci 2017;18:E1179. [PMID: 28587163 DOI: 10.3390/ijms18061179] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
88 Ogino S, Lochhead P, Giovannucci E, Meyerhardt JA, Fuchs CS, Chan AT. Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology. Oncogene. 2014;33:2949-2955. [PMID: 23792451 DOI: 10.1038/onc.2013.244] [Cited by in Crossref: 83] [Cited by in F6Publishing: 83] [Article Influence: 10.4] [Reference Citation Analysis]
89 Gardner K. The Science of Cancer Health Disparities: A Young Discipline with an Old Heritage. Am J Pathol 2018;188:268-70. [PMID: 29137949 DOI: 10.1016/j.ajpath.2017.08.037] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
90 Hamada T, Nowak JA, Milner DA jr. Song M, Ogino S. Integration of microbiology, molecular pathology, and epidemiology: a new paradigm to explore the pathogenesis of microbiome-driven neoplasms. J Pathol. 2019;247:615-628. [PMID: 30632609 DOI: 10.1002/path.5236] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 24.0] [Reference Citation Analysis]
91 Shibata T, Aburatani H. Exploration of liver cancer genomes. Nat Rev Gastroenterol Hepatol. 2014;11:340-349. [PMID: 24473361 DOI: 10.1038/nrgastro.2014.6] [Cited by in Crossref: 113] [Cited by in F6Publishing: 100] [Article Influence: 16.1] [Reference Citation Analysis]
92 Valdespino V, Valdespino PM. Potential of epigenetic therapies in the management of solid tumors. Cancer Manag Res 2015;7:241-51. [PMID: 26346546 DOI: 10.2147/CMAR.S70358] [Cited by in Crossref: 37] [Cited by in F6Publishing: 16] [Article Influence: 6.2] [Reference Citation Analysis]
93 Worthman CM, Dockray S, Marceau K. Puberty and the Evolution of Developmental Science. J Res Adolesc 2019;29:9-31. [PMID: 30869841 DOI: 10.1111/jora.12411] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
94 Hamada T, Nishihara R, Ogino S. Post-colonoscopy colorectal cancer: the key role of molecular pathological epidemiology. Transl Gastroenterol Hepatol 2017;2:9. [PMID: 28275741 DOI: 10.21037/tgh.2017.01.05] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
95 Ogino S, Nishihara R, VanderWeele TJ, Wang M, Nishi A, Lochhead P, Qian ZR, Zhang X, Wu K, Nan H, Yoshida K, Milner DA, Chan AT, Field AE, Camargo CA, Williams MA, Giovannucci EL. Review Article: The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-neoplastic Diseases in the Era of Precision Medicine. Epidemiology. 2016;27:602-611. [PMID: 26928707 DOI: 10.1097/ede.0000000000000471] [Cited by in Crossref: 116] [Cited by in F6Publishing: 83] [Article Influence: 38.7] [Reference Citation Analysis]
96 Hanyuda A, Ogino S, Qian ZR, Nishihara R, Song M, Mima K, Inamura K, Masugi Y, Wu K, Meyerhardt JA, Chan AT, Fuchs CS, Giovannucci EL, Cao Y. Body mass index and risk of colorectal cancer according to tumor lymphocytic infiltrate. Int J Cancer 2016;139:854-68. [PMID: 27037951 DOI: 10.1002/ijc.30122] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 5.6] [Reference Citation Analysis]
97 Mehta AM, Osse M, Kolkman-Uljee S, Fleuren GJ, Jordanova ES. Molecular backgrounds of ERAP1 downregulation in cervical carcinoma. Anal Cell Pathol (Amst) 2015;2015:367837. [PMID: 26146606 DOI: 10.1155/2015/367837] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
98 Ryan BM, Wolff RK, Valeri N, Khan M, Robinson D, Paone A, Bowman ED, Lundgreen A, Caan B, Potter J. An analysis of genetic factors related to risk of inflammatory bowel disease and colon cancer. Cancer Epidemiol. 2014;38:583-590. [PMID: 25132422 DOI: 10.1016/j.canep.2014.07.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
99 Ogino S, Nowak JA, Hamada T, Phipps AI, Peters U, Milner DA, Giovannucci EL, Nishihara R, Giannakis M, Garrett WS, Song M. Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine. Gut. 2018;67:1168-1180. [PMID: 29437869 DOI: 10.1136/gutjnl-2017-315537] [Cited by in Crossref: 93] [Cited by in F6Publishing: 83] [Article Influence: 31.0] [Reference Citation Analysis]
100 Køllgaard T, Ugurel-Becker S, Idorn M, Andersen MH, Becker JC, Straten PT. Pre-Vaccination Frequencies of Th17 Cells Correlate with Vaccine-Induced T-Cell Responses to Survivin-Derived Peptide Epitopes. PLoS One 2015;10:e0131934. [PMID: 26176858 DOI: 10.1371/journal.pone.0131934] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
101 Monteiro S, Gonçalves TC, Magalhães J, Cotter J. Upper gastrointestinal bleeding risk scores: Who, when and why? World J Gastrointest Pathophysiol 2016;7:86-96. [PMID: 26909231 DOI: 10.4291/wjgp.v7.i1.86] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 11] [Article Influence: 4.6] [Reference Citation Analysis]
102 Epplein M, Bostick RM, Mu L, Ogino S, Braithwaite D, Kanetsky PA. Challenges and opportunities in international molecular cancer prevention research: An ASPO Molecular Epidemiology and the Environment and International Cancer Prevention Interest Groups Report. Cancer Epidemiol Biomarkers Prev. 2014;23:2613-2617. [PMID: 25277796 DOI: 10.1158/1055-9965.epi-14-0848] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
103 Wang M, Zhu J, Lubman DM, Gao C. Aberrant glycosylation and cancer biomarker discovery: a promising and thorny journey. Clin Chem Lab Med 2019;57:407-16. [PMID: 30138110 DOI: 10.1515/cclm-2018-0379] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 19.5] [Reference Citation Analysis]
104 Ogino S, Nowak JA, Hamada T, Milner DA Jr, Nishihara R. Insights into Pathogenic Interactions Among Environment, Host, and Tumor at the Crossroads of Molecular Pathology and Epidemiology. Annu Rev Pathol. 2019;14:83-103. [PMID: 30125150 DOI: 10.1146/annurev-pathmechdis-012418-012818] [Cited by in Crossref: 87] [Cited by in F6Publishing: 79] [Article Influence: 29.0] [Reference Citation Analysis]
105 Grageda M, Silveyra P, Thomas NJ, DiAngelo SL, Floros J. DNA methylation profile and expression of surfactant protein A2 gene in lung cancer. Exp Lung Res 2015;41:93-102. [PMID: 25514367 DOI: 10.3109/01902148.2014.976298] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
106 Bella F, Godos J, Ippolito A, Di Prima A, Sciacca S. Differences in the association between empirically derived dietary patterns and cancer: a meta-analysis. Int J Food Sci Nutr 2017;68:402-10. [PMID: 27894200 DOI: 10.1080/09637486.2016.1261087] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
107 Berg M, Hagland HR, Søreide K. Comparison of CpG island methylator phenotype (CIMP) frequency in colon cancer using different probe- and gene-specific scoring alternatives on recommended multi-gene panels. PLoS One 2014;9:e86657. [PMID: 24466191 DOI: 10.1371/journal.pone.0086657] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
108 Hamada T, Keum N, Nishihara R, Ogino S. Molecular pathological epidemiology: new developing frontiers of big data science to study etiologies and pathogenesis. J Gastroenterol. 2017;52:265-275. [PMID: 27738762 DOI: 10.1007/s00535-016-1272-3] [Cited by in Crossref: 65] [Cited by in F6Publishing: 62] [Article Influence: 13.0] [Reference Citation Analysis]
109 Lochhead P, Nishihara R, Qian ZR, Mima K, Cao Y, Sukawa Y, Kim SA, Inamura K, Zhang X, Wu K, Giovannucci E, Meyerhardt JA, Chan AT, Fuchs CS, Ogino S. Postdiagnostic intake of one-carbon nutrients and alcohol in relation to colorectal cancer survival. Am J Clin Nutr 2015;102:1134-41. [PMID: 26423386 DOI: 10.3945/ajcn.115.115162] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
110 Ng JM, Yu J. Promoter hypermethylation of tumour suppressor genes as potential biomarkers in colorectal cancer. Int J Mol Sci. 2015;16:2472-2496. [PMID: 25622259 DOI: 10.3390/ijms16022472] [Cited by in Crossref: 85] [Cited by in F6Publishing: 70] [Article Influence: 14.2] [Reference Citation Analysis]
111 Guerrero-Bosagna C, Skinner MK. Environmental epigenetics and effects on male fertility. Adv Exp Med Biol 2014;791:67-81. [PMID: 23955673 DOI: 10.1007/978-1-4614-7783-9_5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
112 Nishi A, Milner DA Jr, Giovannucci EL, Nishihara R, Tan AS, Kawachi I, Ogino S. Integration of molecular pathology, epidemiology and social science for global precision medicine. Expert Rev Mol Diagn 2016;16:11-23. [PMID: 26636627 DOI: 10.1586/14737159.2016.1115346] [Cited by in Crossref: 64] [Cited by in F6Publishing: 49] [Article Influence: 10.7] [Reference Citation Analysis]
113 Mima K, Nishihara R, Yang J, Dou R, Masugi Y, Shi Y, da Silva A, Cao Y, Song M, Nowak J, Gu M, Li W, Morikawa T, Zhang X, Wu K, Baba H, Giovannucci EL, Meyerhardt JA, Chan AT, Fuchs CS, Qian ZR, Ogino S. MicroRNA MIR21 (miR-21) and PTGS2 Expression in Colorectal Cancer and Patient Survival. Clin Cancer Res 2016;22:3841-8. [PMID: 26957558 DOI: 10.1158/1078-0432.CCR-15-2173] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 6.8] [Reference Citation Analysis]
114 Alnabulsi A, Murray GI. Integrative analysis of the colorectal cancer proteome: potential clinical impact. Expert Rev Proteomics 2016;13:917-27. [PMID: 27598033 DOI: 10.1080/14789450.2016.1233062] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
115 Rajpoot M, Sharma AK, Sharma A, Gupta GK. Understanding the microbiome: Emerging biomarkers for exploiting the microbiota for personalized medicine against cancer. Semin Cancer Biol. 2018;52:1-8. [PMID: 29425888 DOI: 10.1016/j.semcancer.2018.02.003] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 17.0] [Reference Citation Analysis]
116 Al-Shaheri FN, Al-Shami KM, Gamal EH, Mahasneh AA, Ayoub NM. Association of DNA repair gene polymorphisms with colorectal cancer risk and treatment outcomes. Exp Mol Pathol 2020;113:104364. [PMID: 31881200 DOI: 10.1016/j.yexmp.2019.104364] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
117 Chen CH, Sheng Jiang S, Hsieh LL, Tang R, Hsiung CA, Tsai HJ, Chang IS. DNA Methylation Identifies Loci Distinguishing Hereditary Nonpolyposis Colorectal Cancer Without Germ-Line MLH1/MSH2 Mutation from Sporadic Colorectal Cancer. Clin Transl Gastroenterol 2016;7:e208. [PMID: 27977020 DOI: 10.1038/ctg.2016.59] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
118 Bondarenko NA, Bondarenko NA. [Behavior disorder in rats induced by Madopar and its pharmacological correction]. Farmakol Toksikol. 1985;48:31-34. [PMID: 2864283 DOI: 10.1007/s40495-017-0088-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 0.5] [Reference Citation Analysis]
119 Ogino S, Campbell PT, Nishihara R, Phipps AI, Beck AH, Sherman ME, Chan AT, Troester MA, Bass AJ, Fitzgerald KC, Irizarry RA, Kelsey KT, Nan H, Peters U, Poole EM, Qian ZR, Tamimi RM, Tchetgen Tchetgen EJ, Tworoger SS, Zhang X, Giovannucci EL, van den Brandt PA, Rosner BA, Wang M, Chatterjee N, Begg CB. Proceedings of the second international molecular pathological epidemiology (MPE) meeting. Cancer Causes Control 2015;26:959-72. [PMID: 25956270 DOI: 10.1007/s10552-015-0596-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
120 Itonaga M, Matsuzaki I, Warigaya K, Tamura T, Shimizu Y, Fujimoto M, Kojima F, Ichinose M, Murata S. Novel Methodology for Rapid Detection of KRAS Mutation Using PNA-LNA Mediated Loop-Mediated Isothermal Amplification. PLoS One 2016;11:e0151654. [PMID: 26999437 DOI: 10.1371/journal.pone.0151654] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 7.2] [Reference Citation Analysis]
121 Wang J, Shen C, Fu Y, Yu T, Song J. The associations between five polymorphisms of vascular endothelial growth factor and renal cell carcinoma risk: an updated meta-analysis. Onco Targets Ther 2017;10:1725-34. [PMID: 28356760 DOI: 10.2147/OTT.S125965] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
122 Nishihara R, VanderWeele TJ, Shibuya K, Mittleman MA, Wang M, Field AE, Giovannucci E, Lochhead P, Ogino S. Molecular pathological epidemiology gives clues to paradoxical findings. Eur J Epidemiol 2015;30:1129-35. [PMID: 26445996 DOI: 10.1007/s10654-015-0088-4] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
123 Huang X, Yang Z, Xie Q, Zhang Z, Zhang H, Ma J. Natural products for treating colorectal cancer: A mechanistic review. Biomedicine & Pharmacotherapy 2019;117:109142. [DOI: 10.1016/j.biopha.2019.109142] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 17.0] [Reference Citation Analysis]
124 Hagland HR, Søreide K. Cellular metabolism in colorectal carcinogenesis: Influence of lifestyle, gut microbiome and metabolic pathways. Cancer Lett 2015;356:273-80. [PMID: 24614287 DOI: 10.1016/j.canlet.2014.02.026] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 5.3] [Reference Citation Analysis]
125 Liang Y, Zhang C, Dai DQ. Identification of differentially expressed genes regulated by methylation in colon cancer based on bioinformatics analysis. World J Gastroenterol. 2019;25:3392-3407. [PMID: 31341364 DOI: 10.3748/wjg.v25.i26.3392] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
126 Gong J, Hutter CM, Newcomb PA, Ulrich CM, Bien SA, Campbell PT, Baron JA, Berndt SI, Bezieau S, Brenner H, Casey G, Chan AT, Chang-Claude J, Du M, Duggan D, Figueiredo JC, Gallinger S, Giovannucci EL, Haile RW, Harrison TA, Hayes RB, Hoffmeister M, Hopper JL, Hudson TJ, Jeon J, Jenkins MA, Kocarnik J, Küry S, Le Marchand L, Lin Y, Lindor NM, Nishihara R, Ogino S, Potter JD, Rudolph A, Schoen RE, Schrotz-King P, Seminara D, Slattery ML, Thibodeau SN, Thornquist M, Toth R, Wallace R, White E, Jiao S, Lemire M, Hsu L, Peters U; CCFR and GECCO. Genome-Wide Interaction Analyses between Genetic Variants and Alcohol Consumption and Smoking for Risk of Colorectal Cancer. PLoS Genet 2016;12:e1006296. [PMID: 27723779 DOI: 10.1371/journal.pgen.1006296] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
127 Begg CB, Orlow I, Zabor EC, Arora A, Sharma A, Seshan VE, Bernstein JL. Identifying Etiologically Distinct Sub-Types of Cancer: A Demonstration Project Involving Breast Cancer. Cancer Med 2015;4:1432-9. [PMID: 25974664 DOI: 10.1002/cam4.456] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
128 Sepede G, Tavino M, Santacroce R, Fiori F, Salerno RM, Di Giannantonio M. Functional magnetic resonance imaging of internet addiction in young adults. World J Radiol 2016;8:210-25. [PMID: 26981230 DOI: 10.4329/wjr.v8.i2.210] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
129 Rogojanu R, Thalhammer T, Thiem U, Heindl A, Mesteri I, Seewald A, Jäger W, Smochina C, Ellinger I, Bises G. Quantitative Image Analysis of Epithelial and Stromal Area in Histological Sections of Colorectal Cancer: An Emerging Diagnostic Tool. Biomed Res Int 2015;2015:569071. [PMID: 26579535 DOI: 10.1155/2015/569071] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
130 Janssens GE, Houtkooper RH. Identification of longevity compounds with minimized probabilities of side effects. Biogerontology 2020;21:709-19. [PMID: 32562114 DOI: 10.1007/s10522-020-09887-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
131 Haque TR, Bradshaw PT, Crockett SD. Risk factors for serrated polyps of the colorectum. Dig Dis Sci. 2014;59:2874-2889. [PMID: 25030942 DOI: 10.1007/s10620-014-3277-1] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 4.4] [Reference Citation Analysis]
132 Xu MD, Qi P, Du X. Long non-coding RNAs in colorectal cancer: implications for pathogenesis and clinical application. Mod Pathol 2014;27:1310-20. [PMID: 24603586 DOI: 10.1038/modpathol.2014.33] [Cited by in Crossref: 62] [Cited by in F6Publishing: 61] [Article Influence: 8.9] [Reference Citation Analysis]
133 Richiardi L, Barone-Adesi F, Pearce N. Cancer subtypes in aetiological research. Eur J Epidemiol 2017;32:353-61. [PMID: 28497292 DOI: 10.1007/s10654-017-0253-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
134 Dominguez-Valentin M, Therkildsen C, Da Silva S, Nilbert M. Familial colorectal cancer type X: genetic profiles and phenotypic features. Mod Pathol 2015;28:30-6. [PMID: 24743215 DOI: 10.1038/modpathol.2014.49] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
135 Guerrero-Preston R, Hadar T, Ostrow KL, Soudry E, Echenique M, Ili-Gangas C, Pérez G, Perez J, Brebi-Mieville P, Deschamps J, Morales L, Bayona M, Sidransky D, Matta J. Differential promoter methylation of kinesin family member 1a in plasma is associated with breast cancer and DNA repair capacity. Oncol Rep 2014;32:505-12. [PMID: 24927296 DOI: 10.3892/or.2014.3262] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
136 Nishi A, Kawachi I, Koenen KC, Wu K, Nishihara R, Ogino S. Lifecourse epidemiology and molecular pathological epidemiology. Am J Prev Med. 2015;48:116-119. [PMID: 25528613 DOI: 10.1016/j.amepre.2014.09.031.4274745] [Reference Citation Analysis]
137 Kyriazis M. Translating laboratory anti-aging biotechnology into applied clinical practice: Problems and obstacles. WJTM 2015;4:51. [DOI: 10.5528/wjtm.v4.i2.51] [Cited by in CrossRef: 1] [Article Influence: 0.2] [Reference Citation Analysis]
138 Gelato KA, Shaikhibrahim Z, Ocker M, Haendler B. Targeting epigenetic regulators for cancer therapy: modulation of bromodomain proteins, methyltransferases, demethylases, and microRNAs. Expert Opinion on Therapeutic Targets 2016;20:783-99. [DOI: 10.1517/14728222.2016.1134490] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 6.2] [Reference Citation Analysis]